knowledge -WSS

knowledge

author：entertainment 2025-10-01 23:03:22 - browse：4621

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： STAT Wunderkinds: Ruey Hu's digital tools for parsing research

WSS

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Testing for cancer recurrence creates a new limbo for patients

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

AI used to predict Covid

First Opinion Podcast: How to protect health care in times of war

CDC recommends rationing of RSV shot due to shortages

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Latest bird flu infection made farmworker sicker than earlier cases

Jerome Adams on the need for new antivirals for Covid

Telehealth options flood the market as retailers push virtual care

Trump demands the U.S. pay no more for drugs than other countries … again

CDC recommends rationing of RSV shot due to shortages

Hepatitis C has a cure — but many Americans still lack access to it

Adam's Biotech Scorecard: Do Sarepta's exon

Apple is now the first public company to be valued at $3 trillion

Prosthetic arm enables patients to feel the objects they grip

explore

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

The pink breast cancer awareness ribbon needs a redesign

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Startling documents reveal new facets of Sacklers' opioid empire

Readout Newsletter: XBI biotech index, Akero Therapeutics

iTeos Therapeutics debuts first data on TIGIT

knowledge

hotspot

focus

hotspot